Abstract

Introduction: One of the popular questionnaires for screening neuropathic pain is the DN4 (Douleur Neuropathique 4) which has been translated into many languages and validated in different populations. So, we wanted to determine the Persian version of this questionnaire’s reliability and validity to differentiate neuropathic pain from other painful non-neuropathic conditions. Methods: This cross-sectional study was conducted on 120 patients who suffered from chronic pain referred to the Physical Medicine and Rehabilitation Department at the three great referral hospitals in Tehran, Iran in 2016. In this study, a modified version of DN4 was used to validate adding a question related to the appearance of pain in an especial joint and adding visual analogue scaling (VAS) score in each item. Results: The modified DN4 questionnaire had high reliability for assessing neuropathic pain with the Cronbach’s alpha coefficient of 0.874. The correlation coefficients obtained by the retest intra-class correlation test ranged from 0.650 to 0.941. Also, the internal consistency of Spearman’s R coefficients ranged from 0.482 to 0.904. Test-retest reliability analysis also showed a higher intraclass correlation (ICC) value in the neuropathic than non-neuropathic pain group (0.85 vs0.73). The modified DN4 questionnaire could effectively discriminate neuropathic pain from non-neuropathic pain with the area under the curve (ROC) of 0.989 (95% CI: 971–1000, P < 0.001). The best cutoff value for the modified DN4 questionnaire to diagnose neuropathic pain was 5, yielding a sensitivity of 98.3% and a specificity of 90.3%. Conclusion: Applying the new modified Persian version of DN4 achieved by adding a VAS score and a new question related to the appearance of pain in an especial joint led to high reliability and validity for this tool to discriminate neuropathic from non-neuropathic pain.

Highlights

  • One of the popular questionnaires for screening neuropathic pain is the DN4 (Douleur Neuropathique 4) which has been translated into many languages and validated in different populations

  • We wanted to determine the Persian version of this questionnaire’s reliability and validity to differentiate neuropathic pain from other painful non-neuropathic conditions. This cross-sectional study was conducted on 120 patients who suffered from chronic pain referred to the Physical Medicine and Rehabilitation Department at the three great referral hospitals in Tehran, Iran in 2016

  • Applying the new modified Persian version of DN4 achieved by adding a visual analogue scaling (VAS) score and a new question related to the appearance of pain in an especial joint led to high reliability and validity for this tool to discriminate neuropathic from non-neuropathic pain

Read more

Summary

Introduction

One of the popular questionnaires for screening neuropathic pain is the DN4 (Douleur Neuropathique 4) which has been translated into many languages and validated in different populations. Conclusion: Applying the new modified Persian version of DN4 achieved by adding a VAS score and a new question related to the appearance of pain in an especial joint led to high reliability and validity for this tool to discriminate neuropathic from non-neuropathic pain. Neuropathic pain is a complex problematic condition characterized by chronic pain accompanied by injury and dysfunction of the nerve fibers especially the somatosensory system.[1] Etiologically, several causes including diabetes mellitus, alcoholism, musculoskeletal disorders, nerve injuries, multiple sclerosis, parkinsonism, chemotherapy-induced neuropathy, tumor infiltration, spinal surgical interventions, shingles, HIV infection or post-herpetic neuralgia have been suggested.[2,3,4] Neuropathic pain is usually described as a burning or shooting pain with numbness and tingling In this regard, this pain diagnosis is based on interviews and accurate physical examination to discover the primary source of pain and its-related triggering.[5] no gold standard tool has been introduced for the final diagnosis of neuropathic pain.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.